CVX Stock: Piper Sandler Raises Price Target to $242, Reaffirms Buy on Chevron

March 13, 2026

By TrendSpider Editor

CVX Stock: Piper Sandler Raises Price Target to $242, Reaffirms Buy on Chevron

Piper Sandler analyst Ryan Todd reaffirmed a Buy rating on Chevron Corporation and significantly raised the price target to $242 from a prior $179, representing a $63 increase in the firm's valuation outlook. CVX is currently trading at $195.45, down 0.77% in today's session, yet the stock sits near the top of its 52-week range of $132.04 to $198.88, suggesting the market has already been pricing in meaningful strength. With the new $242 target implying notable additional upside from current levels, the analyst action puts fresh institutional conviction behind one of the largest integrated energy names in the market.

Key Drivers of the CVX Stock Move

Main Catalyst: Piper Sandler analyst Ryan Todd confirmed a Buy rating on CVX while lifting the price target substantially to $242 from $179, a raise of $63. This is the sole analyst action recorded and reflects a single confirmation with an upgraded valuation, not a new initiation or a rating change from a lower tier.
Bull Case: The revised $242 price target sits well above the current price of $195.45 and even above the 52-week high of $198.88, signaling that Piper Sandler sees room for CVX to break into new territory and sustain further gains from here. A buy-side reaffirmation with a sharply higher target adds credibility to the stock's proximity to its 52-week high.
Bear Case: Despite the bullish analyst call, CVX is trading down 0.77% today and remains just below its 52-week high of $198.88, raising the question of whether the stock is running into near-term resistance after a significant run from the 52-week low of $132.04. The market's muted or negative reaction to a positive analyst revision may indicate that the upside case is already partially priced in.

The forward setup for CVX looks constructive on a technical basis, with the stock holding near multi-month highs and now carrying fresh institutional support from a well-followed analyst. The $242 consensus price target leaves roughly 23% implied upside from the current price of $195.45 if the stock can clear the 52-week high ceiling at $198.88. The near-term question is whether CVX can absorb selling pressure at that resistance level and use today's analyst action as a catalyst for a breakout. Broader energy market conditions, including oil price trajectory and capital return expectations from major integrated producers, will likely serve as the macro backdrop that either validates or tests the Piper Sandler thesis in the weeks ahead.

CVX Analyst Ratings and Price Targets

Piper Sandler, through analyst Ryan Todd, confirmed a Buy rating on Chevron Corporation on March 13, 2026, and raised the price target to $242 from a prior $179. There were no upgrades or downgrades recorded in the current action summary. The average price target based on available data stands at $242, aligned with the single action on file. The $242 target represents a meaningful premium to both the current price of $195.45 and the 52-week high of $198.88, positioning Piper Sandler as firmly constructive on CVX's forward valuation.

CVX Seasonality

Mid-March has historically been a transitional period for major integrated energy stocks, as the market begins to factor in spring demand expectations for refined products and any shifts in global crude supply dynamics heading into the second quarter. For CVX specifically, analyst activity and institutional repositioning in this window can carry added weight given the proximity to first-quarter earnings season, which typically arrives in late April and often serves as the next major price catalyst.

CVX Relative Performance

CVX is trading at $195.45 today, down 0.77%, and is positioned near the upper end of its 52-week range of $132.04 to $198.88, indicating that on a relative basis the stock has been one of the stronger performers over the trailing year within the large-cap energy space. The current price reflects a gain of roughly 48% from the 52-week low, underscoring the significant recovery and momentum the stock has carried into the current analyst reaffirmation.